PUBLIC CONTRACT · 2024
PQ/2415/2024 Medicamentos ExclusivosCPA 491/2023
- Contract value
- €634,452.00
- Signed on
- 2 August 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11305515PUBLISHED SUBJECT
PQ/2415/2024 Medicamentos ExclusivosCPA 491/2023
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- JANSSEN CILAG FARMACEUTICA, LDA. · Tax ID 500189412
- Bidder
- LAB. PFIZER, LDA. · Tax ID 500162166
- Bidder
- TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
- Bidder
- ASTRAZENECA - PROD.FARMACEUTICOS, LDA. · Tax ID 502942240
Values and timeline
- Contract price
- €634,452.00
- Procedure base price
- €1,034,780.32
- Total effective price
- Not reported on Portal BASE
- Publication date
- 25 March 2025
- Award date
- 2 August 2024
- Signing date
- 2 August 2024
- Performance period
- 153 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7149965
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.